Natixis Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$207K Buy
2023
Q3
Sell
2023
Q2
$200K Sell
2023
Q1
$213K Buy
2022
Q4
Sell
2022
Q3
$212K Buy
2022
Q1
Sell
2021
Q4
$370K Sell
2021
Q3
$455K Sell
2021
Q2
$435K Sell
2021
Q1
$556K Sell
2020
Q4
$345K Buy